Our results demonstrated that patients with Lynch syndrome harboring at least one risky genotype in MUTYH, NUDT1, and ERCC2 SNPs were at an increased risk of CRC compared to those without risky genotype. This evidence concerns the gene ERCC2 and colorectal carcinoma.